Recombinant NMI anticorps

N° du produit ABIN7881750

Cet anticorps Lapin Monoclonal détecte spécifiquement NMI dans WB, IHC, IF, IP et ICC. Il présente une réactivité avec des échantillons de Humain.

Aperçu rapide pour Recombinant NMI anticorps (ABIN7881750)

Antigène: NMI (N-Myc (And STAT) Interactor (NMI))

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Lapin

Clonalité: Monoclonal

Conjugué: Cet anticorp NMI est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Immunoprecipitation (IP), Immunocytochemistry (ICC)

Clone: 30N95

Détail du produit anti-NMI anticorps

Fonction: NMI Antibody / N myc and STAT interactor

Purification: Affinity-chromatography

Immunogène: A synthesized peptide derived from human NMI was used as the immunogen for the NMI antibody.

Isotype: IgG

Information d'application

Indications d'application: Optimal dilution of the NMI antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol, 0.4-0.5 mg/mL BSA

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store the NMI antibody at -20oC.

Détails sur NMI

Antigène: NMI (N-Myc (And STAT) Interactor (NMI))

Autre désignation: NMI

Sujet: NMI antibody detects N myc and STAT interactor, a coactivator protein encoded by the NMI gene. NMI interacts with transcription factors such as STATs and c-Myc, enhancing their transcriptional activity. It plays roles in cytokine signaling, oncogene regulation, and immune responses. By linking signal transduction to gene expression, NMI contributes to cellular responses to external cues.

NMI antibody is widely used in immunology, oncology, and signal transduction research. NMI expression is induced by interferons and other cytokines, where it modulates STAT mediated transcription. It also interacts with c-Myc and N-Myc, affecting oncogenic transcriptional programs. By detecting NMI, researchers can explore how transcriptional coactivators regulate immune signaling and cancer pathways.

In western blot assays, NMI antibody identifies protein bands of expected size in cytokine stimulated cells. Immunohistochemistry reveals expression in immune tissues, while immunofluorescence highlights nuclear and cytoplasmic distribution depending on activation state. These applications provide robust tools for analyzing NMI activity in signaling networks.

NMI has been implicated in tumorigenesis. Its expression is elevated in breast and cervical cancers, where it interacts with oncogenes and alters signaling outcomes. Conversely, NMI may also play tumor suppressive roles in certain contexts, reflecting its complex regulation. By applying NMI antibody, scientists can dissect the dual roles of this coactivator in cancer biology.

NMI also regulates antiviral responses and inflammation by modulating STAT signaling downstream of interferons. This positions NMI as a bridge between innate immunity and transcriptional responses. Its interactions with multiple transcription factors highlight its versatility in shaping gene expression outcomes.

NMI antibody from NSJ Bioreagents offers reliable specificity for investigating transcriptional regulation and immune signaling. Its performance across multiple assays supports accurate detection of NMI in basic and disease related research.

UniProt: Q13287